Loading...
XHKG
8037
Market cap84mUSD
Jul 16, Last price  
0.68HKD
1D
4.62%
Jan 2017
88.89%
IPO
-96.49%
Name

China Biotech Services Holdings Ltd

Chart & Performance

D1W1MN
P/E
—
P/S
9.41
EPS
—
Div Yield, %
—
Shrs. gr., 5y
0.16%
Rev. gr., 5y
3.55%
Revenues
71m
-66.74%
197,457,000243,386,000270,753,000272,277,000160,522,00084,184,00045,017,000101,354,00085,300,000140,385,00034,127,00086,565,000105,135,00070,304,00059,214,000655,792,000623,761,0001,851,532,000211,985,00070,509,000
Net income
-198m
L+107.60%
25,165,000528,000-38,333,000-37,425,000-83,561,000-16,465,000-43,555,000-20,698,000-60,231,200-82,929,000-62,269,000-50,151,000-63,022,000-64,250,000-107,483,000167,623,000132,572,000705,568,000-95,447,000-198,146,000
CFO
0k
-100.00%
18,596,00022,720,000-18,547,000-20,636,0008,362,000-1,508,000-27,020,000-1,574,000-41,720,000-40,011,000-85,123,000-25,392,000-56,951,000-14,759,000-30,306,000421,999,00040,505,000482,748,000195,193,0000
Dividend
May 19, 20230.01 HKD/sh

Profile

China Biotech Services Holdings Limited, an investment holding company, provides medical laboratory testing and health check services in the People's Republic of China and Hong Kong. The company operates through five segments: Immunotherapy, Pharmaceutical Products, Medical and Health Related Services, Securities, Insurance brokerage, and Others segments. It also engages in the research, development, manufacture, sale, and distribution of health related and pharmaceutical products; trading of securities; money lending business; provision of tumor immune cell therapy, immune cell storage, and health management services; and provision of coordination of healthcare providers services. In addition, the company markets and sells health supplements, slimming pills, Chinese medicines, and beauty products; trades in pharmaceutical intermediates; and offers insurance brokerage services. Further, it provides property investment and logistic services. The company was formerly known as Rui Kang Pharmaceutical Group Investments Limited and changed its name to China Biotech Services Holdings Limited in November 2017. China Biotech Services Holdings Limited was founded in 1996 and is headquartered in Causeway Bay, Hong Kong.
URL
http://www.cbshhk.com/
IPO date
Jun 17, 2004
Employees
187
Domiciled in
HK
Incorporated in
BM

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
70,509
-66.74%
211,985
-88.55%
1,851,532
196.83%
Cost of revenue
251,982
359,655
1,033,217
Unusual Expense (Income)
NOPBT
(181,473)
(147,670)
818,315
NOPBT Margin
44.20%
Operating Taxes
943
(1,319)
157,258
Tax Rate
19.22%
NOPAT
(182,416)
(146,351)
661,057
Net income
(198,146)
107.60%
(95,447)
-113.53%
705,568
432.21%
Dividends
(9,632)
Dividend yield
1.30%
Proceeds from repurchase of equity
(3,637)
(2,985)
BB yield
0.49%
0.27%
Debt
Debt current
144,404
94,669
16,621
Long-term debt
50,932
21,283
85,510
Deferred revenue
Other long-term liabilities
51,525
22,252
Net debt
133,194
(13,055)
(218,357)
Cash flow
Cash from operating activities
195,193
482,748
CAPEX
(62,884)
(69,750)
Cash from investing activities
(67,531)
(256,311)
Cash from financing activities
(149,412)
(281,959)
FCF
(165,527)
(9,778)
377,752
Balance
Cash
18,913
72,087
92,770
Long term investments
43,229
56,920
227,718
Excess cash
58,617
118,408
227,911
Stockholders' equity
(251,794)
34
335,828
Invested Capital
733,539
591,088
460,647
ROIC
141.66%
ROCE
117.50%
EV
Common stock shares outstanding
968,491
963,231
963,231
Price
0.51
-33.77%
0.77
-33.04%
1.15
-16.67%
Market cap
493,930
-33.40%
741,688
-33.04%
1,107,716
-16.79%
EV
604,570
756,605
1,113,204
EBITDA
(181,473)
(92,090)
884,716
EV/EBITDA
1.26
Interest
5,311
3,495
Interest/NOPBT
0.43%